# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. - Amoxicillin sodium clavulanate potassium

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd/42be09ac-3505-441a-a48d-d707c0fbc486/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. published November 16, 2021. Drug: Amoxicillin sodium clavulanate potassium. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 3, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-16
- Drug Name: Amoxicillin sodium clavulanate potassium
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd/bb4825c4-f115-47da-9153-e81b46bcc131/